Literature DB >> 1351881

Role of T-lymphocyte subsets in Rhodococcus equi infection.

P Nordmann1, E Ronco, C Nauciel.   

Abstract

Rhodococcus equi, a facultative intracellular gram-positive bacterium, can induce life-threatening infections in immunocompromised patients, especially those with AIDS. We have studied the mechanism of acquired immunity to this pathogen in a murine model. Protective immunity was induced by live but not killed bacteria. Adoptive transfer of resistance was obtained with spleen cells but not immune serum from mice immunized intravenously 30 days earlier with live bacteria. In normal mice, an intravenous challenge of 5 x 10(6) CFU of R. equi was cleared from the spleen, liver, and lungs within 3 weeks, whereas athymic nude mice were unable to clear the bacteria. In vivo depletion with monoclonal antibodies showed that both CD4+ and CD8+ T-cell subsets participate in the clearance of bacteria and that CD8+ T cells play the major role.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351881      PMCID: PMC257230          DOI: 10.1128/iai.60.7.2748-2752.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Role of antibody to extracellular proteins of Rhodococcus equi in protection against R. equi pneumonia in foals.

Authors:  R S Machang'u; J F Prescott
Journal:  Vet Microbiol       Date:  1991-02-15       Impact factor: 3.293

2.  Influence of different regions of the H-2 complex on the rate of clearance of Salmonella typhimurium.

Authors:  C Nauciel; E Ronco; M Pla
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice.

Authors:  T Koga; M Mitsuyama; T Handa; T Yayama; K Muramori; K Nomoto
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

Review 4.  Rhodococcus equi infection in patients with and without human immunodeficiency virus infection.

Authors:  R L Harvey; J C Sunstrum
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

Review 5.  Rhodococcus equi: an animal and human pathogen.

Authors:  J F Prescott
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  Cellular and humoral immune response of foals to vaccination with Corynebacterium equi.

Authors:  J F Prescott; R J Markham; J A Johnson
Journal:  Can J Comp Med       Date:  1979-10

7.  Experimental subacute foal pneumonia induced by aerosol administration of Corynebacterium equi.

Authors:  R J Martens; R A Fiske; H W Renshaw
Journal:  Equine Vet J       Date:  1982-04       Impact factor: 2.888

8.  The effect of experimental infection with Rhodococcus equi on immunodeficient mice.

Authors:  J A Yager; C A Prescott; D P Kramar; H Hannah; G A Balson; B A Croy
Journal:  Vet Microbiol       Date:  1991-08-30       Impact factor: 3.293

9.  Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection.

Authors:  C Nauciel
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

10.  Roles of CD4+ and CD8+ cells, and the effect of administration of recombinant murine interferon gamma in listerial infection.

Authors:  T Sasaki; M Mieno; H Udono; K Yamaguchi; T Usui; K Hara; H Shiku; E Nakayama
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  22 in total

1.  Nonhealing wound due to Rhodococcus equi in an apparently immunocompetent patient, revealing CD8+ T-lymphocyte deficiency.

Authors:  Eric Denes; Dominique Peignon-Orsoni; François-Xavier Terrade
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

Review 2.  Macrophage-related diseases of the gut: a pathologist's perspective.

Authors:  Xavier Sagaert; Thomas Tousseyn; Gert De Hertogh; Karel Geboes
Journal:  Virchows Arch       Date:  2012-05-11       Impact factor: 4.064

3.  Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.

Authors:  A Marianela Lopez; Melissa T Hines; Guy H Palmer; Debra C Alperin; Stephen A Hines
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Serologic responses to Rhodococcus equi in individuals with and without human immunodeficiency virus infection.

Authors:  V Vullo; C M Mastroianni; M Lichtner; F Mengoni; E Chiappini; C D'Agostino; S Delia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

5.  Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.

Authors:  Stephen A Hines; Diana M Stone; Melissa T Hines; Debby C Alperin; Donald P Knowles; Linda K Norton; Mary J Hamilton; William C Davis; Travis C McGuire
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

6.  Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi.

Authors:  S Giguère; J F Prescott
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi.

Authors:  S Giguère; B N Wilkie; J F Prescott
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins.

Authors:  Kathleen E Hooper-McGrevy; Bruce N Wilkie; John F Prescott
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

9.  Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.